Efficacy of intrathecal baclofen in the treatment of spasticity in stroke;Intérêt de la pompe à baclofène dans le traitement de la spasticité chez l'hémiplégique : à propos d'un cas

Annales de Readaptation et de Medecine Physique

Volumn 50, Issue 3, 2007, Pages 165-169

  Lamotte, D ^a   Cantalloube, S ^a  

^a Hopital Reine Hortense   (France)

Author keywords

Hemiplegia; Hypertonia; Intrathecal baclofen; Spasticity; Stroke

Indexed keywords

BACLOFEN; BOTULINUM TOXIN; DANTROLENE;

ADULT; ARTICLE; ASCHWORTH SCORE; BOLUS INJECTION; BRAIN HEMORRHAGE; CASE REPORT; CEREBROVASCULAR DISEASE; DRUG DOSE INCREASE; DRUG EFFICACY; EJACULATION DISORDER; FUNCTIONAL ASSESSMENT; GAIT; HEADACHE; HEMIPLEGIA; HUMAN; IMPLANTATION; INFUSION PUMP; KINEMATICS; MONOTHERAPY; PAIN; QUADRICEPS FEMORIS MUSCLE; SCORING SYSTEM; SKELETAL MUSCLE; SPASTICITY; STROKE; TREATMENT OUTCOME; TRICEPS BRACHII MUSCLE;

BACLOFEN; CEREBROVASCULAR ACCIDENT; HEMIPLEGIA; HUMANS; INFUSION PUMPS, IMPLANTABLE; INJECTIONS, SPINAL; MALE; MIDDLE AGED; MUSCLE RELAXANTS, CENTRAL; MUSCLE SPASTICITY;

EID: 34047166361     PISSN: 01686054     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annrmp.2006.11.004     Document Type: Article

References (23)

1. Abel N.A., and Smith R.A. Intrathecal baclofen for treatment of intractable spinal spasticity. Arch. Phys. Med. Rehabil. 75 1 (1994) 54-58
2. Albert T., and Yelnik A. Physiotherapy for spasticity. Neurochirurgie 49 2 (2003) 239-246
3. Broseta J., Garcia-March G., Sanchez-Ledesma M.J., Anaya J., and Silva I. Chronic intrathecal baclofen administration in severe spasticity. Stereotact. Funct. Neurosurg. 54-55 (1990) 147-153
4. Cairns K., and Stein J. Motor function improvement following intrathecal baclofen pump placement in a patient with locked-in syndrom. Am. J. Phys. Med. Rehabil. 81 4 (2002) 307-309
5. Denys P., Mane M., Azouvi P., Chartier-Kastler E., Thiebaut J.B., and Bussel B. Side effects of chronic intrathecal baclofen on erection and ejaculation in patients with spinal cord lesions. Arch. Phys. Med. Rehabil. 79 5 (1998) 494-496
6. Francisco G.E. Intrathecal baclofen therapy for stroke-related spasticity. Top. Stroke Rehabil. 8 1 (2001) 36-46
7. Francisco G.E., and Boake C. Improvement in walking speed in poststroke spastic hemiplegia after intrathecal baclofen therapy: a preliminary study. Arch. Phys. Med. Rehabil. 84 8 (2003) 1194-1199
8. Gilmartin R., Bruce D., Storrs B.B., Abbott R., Krach L., Ward J., et al. Intrathecal baclofen for management of spastic cerebral palsy: multicenter trial. J. Child Neurol. 15 2 (2000) 71-77
9. Gracies J.M., Nance P., Elovic E., McGuire J., and Simpson D.M. Traditional pharmacological treatments for spasticity. Part II: General and regional treatments. Muscle Nerve Suppl 6 (1997) S92-S120
10. Guillaume D., Van Havenbergh A., Vloeberghs M., Vidal J., and Roeste G. A clinical study of intrathecal baclofen using a programmable pump for intractable spasticity. Arch. Phys. Med. Rehabil. 86 11 (2005) 2165-2171
11. Herman R.M., D'Luzansky S.C., and Ippolito R. Intrathecal baclofen suppresses central pain in patients with spinal lesions. A pilot study. Clin. J. Pain. 8 4 (1992) 338-345
12. Horn T.S., Yablon S.A., and Stokic D.S. Effect of intrathecal baclofen bolus injection on temporospatial gait characteristics in patients with acquired brain injury. Arch. Phys. Med. Rehabil. 86 6 (2005) 1127-1133
13. Lazorthes Y., Sallerin-Caute B., Verdie J.C., Bastide R., and Carillo J.P. Chronic intrathecal baclofen administration for control of severe spasticity. J. Neurosurg. 72 3 (1990) 393-402
14. Meythaler J.M., Guin-Renfroe S., Brunner R.C., and Hadley M.N. Intrathecal baclofen for spastic hypertonia from stroke. Stroke 32 9 (2001) 2099-2109
15. Meythaler J.M., Guin-Renfroe S., and Hadley M.N. Continuously infused intrathecal baclofen for spastic/dystonic hemiplegia: a preliminary report. Am. J. Phys. Med. Rehabil. 78 3 (1999) 247-254
16. Middel B., Kuipers-Upmeijer H., Bouma J., Staal M., Oenema D., Postma T., et al. Effect of intrathecal baclofen delivered by an implanted programmable pump on health related quality of life in patients with severe spasticity. J. Neurol. Neurosurg. Psychiatry 63 2 (1997) 204-209
17. Penn R.D., Savoy S.M., Corcos D., Latash M., Gottlieb G., Parke B., et al. Intrathecal baclofen for severe spinal spasticity. N. Engl. J. Med. 320 23 (1989) 1517-1521
18. Remy-Neris O., Tiffreau V., Bouilland S., and Bussel B. Intrathecal baclofen in subjects with spastic hemiplegia: assessment of the antispastic effect during gait. Arch. Phys. Med. Rehabil. 84 5 (2003) 643-650
19. Saltuari L., Kronenberg M., Marosi M.J., Kofler M., Russegger L., Rifici C., et al. Indication, efficiency and complications of intrathecal pump supported baclofen treatment in spinal spasticity. Acta Neurol. (Napoli) 14 3 (1992) 187-194
20. Sommerfeld D.K., Eek E.U., Svensson A.K., Holmqvist L.W., and von Arbin M.H. Spasticity after stroke: its occurrence and association with motor impairments and activity limitations. Stroke 35 1 (2004) 134-139
21. Van Schaeybroeck P., Nuttin B., Lagae L., Schrijvers E., Borghgraef C., and Feys P. Intrathecal baclofen for intractable cerebral spasticity: a prospective placebo-controlled, double-blind study. Neurosurgery 46 3 (2000) 603-609 (discussion 609-12)
22. Yelnik A., Albert T., Bonan I., and Laffont I. A clinical guide to assess the role of lower limb extensor overactivity in hemiplegic gait disorders. Stroke 30 3 (1999) 580-585
23. Yelnik A.P. Pharmacology and upper limb poststroke spasticity: a review. International Society of Prosthetics and Orthotics. Ann. Readapt. Med. Phys. 47 8 (2004) 575-589